Open AccessAmerican Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors
Author(s) -
Saslow Debbie,
Castle Philip E.,
Cox J. Thomas,
Davey Diane D.,
Einstein Mark H.,
Ferris Daron G.,
Goldie Sue J.,
Harper Diane M.,
Kinney Walter,
Moscicki AnnaBarbara,
Noller Kenneth L.,
Wheeler Cosette M.,
Ades Terri,
Andrews Kimberly S.,
Doroshenk Mary K.,
Kahn Kelly Green,
Schmidt Christy,
Shafey Omar,
Smith Robert A.,
Partridge Edward E.,
Garcia Francisco
Publication year - 2007
Publication title -
ca: a cancer journal for clinicians
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 62.937
H-Index - 168
eISSN - 1542-4863
pISSN - 0007-9235
DOI - 10.3322/canjclin.57.1.7
Subject(s) - cervical cancer , guideline , human papillomavirus , medicine , hpv vaccines , cervical intraepithelial neoplasia , human papillomavirus vaccine , cancer , gynecology , cancer prevention , oncology , hpv infection , gardasil , pathology
The American Cancer Society (ACS) has developed guidelines for the use of the prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical intraepithelial neoplasia and cervical cancer. These recommendations are based on a formal review of the available evidence. They address the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues. Implications for screening are also discussed.